Insmed Inc [INSM] stock prices are up 0.93% to $68.51 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The INSM shares have gain 4.26% over the last week, with a monthly amount drifted -1.44%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Insmed Inc [NASDAQ: INSM] stock has seen the most recent analyst activity on May 13, 2025, when Jefferies initiated its Buy rating and assigned the stock a price target of $105. Previously, RBC Capital Mkts started tracking the stock with Outperform rating on February 25, 2025, and set its price target to $100. On April 23, 2024, Truist initiated with a Buy rating and assigned a price target of $48 on the stock. Wolfe Research started tracking the stock assigning a Outperform rating and suggested a price target of $42 on February 15, 2024. Wells Fargo initiated its recommendation with a Overweight and recommended $55 as its price target on December 08, 2023. In a note dated July 26, 2023, Guggenheim initiated an Buy rating and provided a target price of $50 on this stock.
The stock price of Insmed Inc [INSM] has been fluctuating between $21.92 and $84.91 over the past year. Currently, Wall Street analysts expect the stock to reach $110 within the next 12 months. Insmed Inc [NASDAQ: INSM] shares were valued at $68.51 at the most recent close of the market. An investor can expect a potential return of 60.56% based on the average INSM price forecast.
Analyzing the INSM fundamentals
The Insmed Inc [NASDAQ:INSM] reported sales of 381.03M for trailing twelve months, representing a surge of 22.94%. Gross Profit Margin for this corporation currently stands at 0.76% with Operating Profit Margin at -2.3%, Pretax Profit Margin comes in at -2.65%, and Net Profit Margin reading is -2.66%. To continue investigating profitability, this company’s Return on Assets is posted at -0.56, Equity is -4.47 and Total Capital is -0.56. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 11.53.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Insmed Inc [NASDAQ:INSM]’s Current Ratio is 5.86. On the other hand, the Quick Ratio is 5.44, and the Cash Ratio is 1.69. Considering the valuation of this stock, the price to sales ratio is 32.75, the price to book ratio is 125.68.
Transactions by insiders
Recent insider trading involved Wise John Drayton, Former Officer, that happened on May 20 ’25 when 7000.0 shares were purchased. Officer, Lewis William completed a deal on May 20 ’25 to buy 27887.0 shares. Meanwhile, Chief Medical Officer Flammer Martina M.D. sold 9925.0 shares on May 15 ’25.
